TSX runs higher on rate cut expectations
WESTBOROUGH, Mass. - Kopin Corporation (NASDAQ:KOPN), a technology company with a market capitalization of $330 million that has seen its stock surge over 90% in the past year, announced Tuesday the first production delivery of its CR3 wearable surgical monitor to Carl Zeiss Meditec, a global medical technology company. According to InvestingPro data, the company maintains a strong balance sheet with more cash than debt.
The FDA-registered and CE-certified head-mounted display system, developed in collaboration with HMDmd, is designed specifically for surgical applications. The lightweight device delivers 3D imagery in full HD resolution, allowing surgeons to view live video feeds from surgical instruments and diagnostic images without turning away from patients. While the company’s revenue grew by 28% in the last twelve months, InvestingPro analysis indicates analysts don’t expect profitability this year.
"The initial delivery of production line devices to Carl Zeiss Meditec marks a significant milestone in our development program," said John Lyon, CEO of HMDmd, in a press release statement.
The CR3 monitor aims to improve surgeon comfort during microsurgery, minimally invasive procedures, digital and robotic surgery, and interventional medicine by eliminating the need to repeatedly shift focus between conventional monitors and patients.
Bill Maffucci, SVP of Business Development & Strategy at Kopin, noted that the company’s display technologies would be integrated with Carl Zeiss Meditec’s operating microscopes.
The production process for these medical-grade head-mounted displays involves selecting advanced components, implementing manufacturing practices, and enforcing quality control measures to ensure compliance with medical standards.
Kopin Corporation specializes in display and optical solutions for defense, enterprise, professional, and consumer products. HMDmd focuses on developing wearable display systems for medical applications, primarily through strategic distribution partnerships with companies integrating these displays into their surgical systems. For deeper insights into Kopin’s financial health and growth prospects, InvestingPro subscribers have access to over 10 additional ProTips and a comprehensive research report, part of their coverage of 1,400+ US stocks.
In other recent news, Kopin Corporation announced a $7.5 million defense contract to supply microdisplays for augmented reality pilot Helmet Mounted Display Systems, bringing its total defense orders for the year to $13.5 million. The company is also set to join the Russell 2000 Index following the 2025 Russell indexes reconstitution, effective from June 27, 2025. This inclusion will expand Kopin’s presence in the investment landscape, as the Russell 2000 is a key performance benchmark utilized by investment managers. Kopin is advancing its AR/VR capabilities with its new NeuralDisplay prototype, which features OLED technology and MicroLED compatibility, enhancing augmented and virtual reality experiences. The company is also showcasing its microdisplays and spatial light modulators at the Laser World of Photonics exhibition in Munich, highlighting its high-resolution binary phase modulator for applications like 3D metrology. Additionally, Kopin is searching for a new Chief Financial Officer following the retirement of Rich Sneider, who played a significant role in the company’s evolution over his 25-year tenure. These developments reflect Kopin’s ongoing efforts to innovate and expand its market reach.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.